Analysen von Keyur Parekh
| 06.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.02.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.02.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 29.01.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.01.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 25.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.01.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 23.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 19.01.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.01.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 15.12.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 11.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.12.17 | GSK buy | Goldman Sachs Group Inc. | |
| 29.11.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 27.11.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.11.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 08.11.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 07.11.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 03.11.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 02.11.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 31.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.10.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 27.10.17 | GSK buy | Goldman Sachs Group Inc. | |
| 25.10.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 25.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 20.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.10.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.10.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.10.17 | GSK buy | Goldman Sachs Group Inc. | |
| 12.10.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.09.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 21.09.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.09.17 | Merck Neutral | Goldman Sachs Group Inc. | |